Anavex Life Sciences Corp.
Hedge Funds Holdings
Last updated:
Anavex Life Sciences Corp.‘s stocks are currently a part of 91 hedge funds’ portfolios, which represents 30% of the total amount of its stocks outstanding. This makes up a total of 12.34M shares of Anavex Life Sciences Corp.. Compared to the previous quarter, the number fell by -54.17% or -14.59M shares fewer. As for the holding position changes, 28.57% (26) of current hedge fund investors increased the number of shares held, 27.47% (25) of current holders sold a part of the shares held, and 8.79% (8) closed the holdings completely. 11 hedge funds are new holders of Anavex Life Sciences Corp. stock in Q1 2023, it is 12.09% of total holders.
Hedge funds holding Anavex Life Sciences Corp. (Q2 2018 – Q1 2023)
| Q2 2018 | 55 |
|---|---|
| Q3 2018 | 47 |
| Q4 2018 | 47 |
| Q1 2019 | 54 |
| Q2 2019 | 57 |
| Q3 2019 | 59 |
| Q4 2019 | 60 |
| Q1 2020 | 67 |
| Q2 2020 | 74 |
| Q3 2020 | 75 |
| Q4 2020 | 88 |
| Q1 2021 | 101 |
| Q2 2021 | 124 |
| Q3 2021 | 131 |
| Q4 2021 | 145 |
| Q1 2022 | 131 |
| Q2 2022 | 145 |
| Q3 2022 | 142 |
| Q4 2022 | 136 |
| Q1 2023 | 91 |
Hedge funds changes in Anavex Life Sciences Corp. positions (Q2 2018 – Q1 2023)
| Q2 2018 | 15 | 15 | 15 | 16 | -6 |
|---|---|---|---|---|---|
| Q3 2018 | 5 | 10 | 15 | 13 | 4 |
| Q4 2018 | 8 | 12 | 10 | 8 | 9 |
| Q1 2019 | 13 | 13 | 15 | 6 | 7 |
| Q2 2019 | 14 | 20 | 12 | 11 | 0 |
| Q3 2019 | 8 | 22 | 13 | 6 | 10 |
| Q4 2019 | 8 | 24 | 8 | 6 | 14 |
| Q1 2020 | 15 | 24 | 15 | 5 | 8 |
| Q2 2020 | 13 | 22 | 20 | 7 | 12 |
| Q3 2020 | 11 | 24 | 22 | 9 | 9 |
| Q4 2020 | 18 | 29 | 23 | 5 | 13 |
| Q1 2021 | 30 | 39 | 22 | 16 | -6 |
| Q2 2021 | 38 | 43 | 25 | 16 | 2 |
| Q3 2021 | 27 | 44 | 29 | 18 | 13 |
| Q4 2021 | 30 | 52 | 31 | 18 | 14 |
| Q1 2022 | 22 | 53 | 28 | 34 | -6 |
| Q2 2022 | 27 | 45 | 33 | 12 | 28 |
| Q3 2022 | 15 | 51 | 31 | 18 | 27 |
| Q4 2022 | 19 | 61 | 28 | 22 | 6 |
| Q1 2023 | 11 | 26 | 25 | 8 | 21 |
Hedge funds changes in Anavex Life Sciences Corp. stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 195,000 | 926,000 |
|---|---|---|
| Q3 2018 | 251,000 | 1,283,000 |
| Q4 2018 | 75,000 | 646,000 |
| Q1 2019 | 74,000 | 912,000 |
| Q2 2019 | 233,000 | 1,375,000 |
| Q3 2019 | 384,000 | 2,319,000 |
| Q4 2019 | 344,000 | 1,874,000 |
| Q1 2020 | 243,000 | 1,983,000 |
| Q2 2020 | 612,000 | 2,844,000 |
| Q3 2020 | 760,000 | 1,719,000 |
| Q4 2020 | 1,539,000 | 2,587,000 |
| Q1 2021 | 12,435,000 | 8,463,000 |
| Q2 2021 | 34,946,000 | 34,773,000 |
| Q3 2021 | 19,041,000 | 18,201,000 |
| Q4 2021 | 19,191,000 | 15,175,000 |
| Q1 2022 | 20,830,000 | 9,477,000 |
| Q2 2022 | 14,415,000 | 19,737,000 |
| Q3 2022 | 15,178,000 | 22,669,000 |
| Q4 2022 | 17,102,032 | 28,029,494 |
| Q1 2023 | 1,402,202,000 | 3,664,836,000 |